Ankita Srivastava, A. Khare, L. Gupta, A. Mittal, S. Mehta, Manisha Balai, G. Bharti
Introduction. Skin tags are known to be associated with several systemic diseases such as diabetes mellitus, obesity, dyslipidemia and cardiovascular diseases. Only a few Indian studies have investigated patients with skin tags for underlying metabolic complications. Objective. To assess the clinico-epidemiological profile of patients with skin tags and evaluate them for underlying metabolic abnormalities. Material and methods. All the patients reporting skin tag(s) at the dermatology outpatient department from October 2013 to September 2014 were included in the study. A detailed general, cutaneous and systemic examination was carried out. The data were analyzed using the c2 test. A p-value < 0.05 was considered significant. Results. Out of 165 enrolled patients, 112 (67.88%) completed the study protocol. Females outnumbered males, the M : F ratio being 1 : 1.11. Most patients (32; 28.57%) were in the age group of 31–40 years. The majority of the patients (77; 68.75%) reported after 1 year of noticing the lesions. The most commonly affected site was the neck (99; 88.39%) followed by the axilla (53; 47.32%). Acanthosis nigricans was the most common skin disease associated with skin tags (37; 33.03%). The diagnostic criteria for metabolic syndrome were fulfilled by 47 (41.96%) patients. The majority of the patients (70; 62.5%) were either overweight or obese. Abnormal glucose tolerance and hypertension were found in 41 (36.6%) and 37 (33.03%) of the patients respectively. Above optimal LDL cholesterol was the most common lipid abnormality, detected in 64 (56.25%) of the cases. Patients with 11 or more skin tags lesions and those with involvement of the thigh, axilla or neck were more likely to have metabolic syndrome. Conclusions. Patients with skin tags should be screened for concomitant diseases such as diabetes, hypertension, dyslipidemia and cardiovascular disease. Early detection of these complications followed by appropriate lifestyle changes and/or drug therapy would be beneficial in terms of reducing the considerable morbidity and mortality. StreSzczenie Wprowadzenie. Włókniaki miękkie (nitkowate, ang. skin tags) występują u pacjentów z cukrzycą, otyłością, dyslipidemią i chorobami układu krążenia. Tylko w kilku pracach indyjskich poszukiwano współistniejących z włókniakami miękkimi chorób metabolicznych. Key WordS: skin tags, metabolic syndrome, acanthosis nigricans, insulin resistance. SłoWA KLuczoWe: włókniaki miękkie, zespół metaboliczny, rogowacenie ciemne, insulinooporność. AddreSS for correSpondence: Ankita Srivastava MD Department of Dermatology, RuhS College of Medical Sciences Jaipur, Rajasthan, India 302033 phone: 917597272523 e-mail: ankitarnt@gmail.com
介绍。众所周知，皮赘与几种全身性疾病有关，如糖尿病、肥胖、血脂异常和心血管疾病。只有少数印度研究调查了皮赘患者潜在的代谢并发症。目标。评估皮赘患者的临床流行病学特征，并评估其潜在的代谢异常。材料和方法。2013年10月至2014年9月在皮肤科门诊报告出现皮赘的所有患者纳入研究。进行了详细的全身、皮肤和全身检查。采用c2检验对数据进行分析。p值< 0.05被认为是显著的。结果。在165名入组患者中，112名(67.88%)完成了研究方案。女性数量多于男性，男女比例为1:1 .11。大多数患者(32例;28.57%)，年龄在31 ~ 40岁。大多数患者(77例;68.75%)在发现病变1年后报告。最常见的受累部位是颈部(99;88.39%)，其次是腋窝(53;47.32%)。黑棘皮病是最常见的与皮赘相关的皮肤病(37;33.03%)。47例(41.96%)患者符合代谢综合征诊断标准。大多数患者(70例;62.5%)超重或肥胖。糖耐量异常41例(36.6%)，高血压37例(33.03%)。低密度脂蛋白胆固醇高于最佳水平是最常见的脂质异常，64例(56.25%)。有11个或更多皮赘病变的患者以及累及大腿、腋窝或颈部的患者更容易出现代谢综合征。结论。有皮赘的患者应筛查是否伴有糖尿病、高血压、血脂异常、心血管疾病等疾病。早期发现这些并发症，然后适当改变生活方式和/或药物治疗，将有助于降低相当大的发病率和死亡率。StreSzczenie Wprowadzenie。Włókniaki miękkie (nitkowate, ang。皮赘)występują u pacjentów z cukrzyczy, otyłością，血脂异常症I chorobami układu krążenia。Tylko w kilku pracach indyjskich poszukiwano współistniejących z włókniakami miękkimi chorób metabolicznych。关键词:皮赘，代谢综合征，黑棘皮病，胰岛素抵抗SłoWA KLuczoWe: włókniaki miękkie, zespół metaboliczny, rogowacenie ciemne, insulinooporność。通信地址:Ankita Srivastava医学博士，印度拉贾斯坦邦斋浦尔RuhS医学院皮肤科302033电话:917597272523电子邮件:ankitarnt@gmail.com
{"title":"A clinicoepidemiological study of skin tags and their association with metabolic syndrome","authors":"Ankita Srivastava, A. Khare, L. Gupta, A. Mittal, S. Mehta, Manisha Balai, G. Bharti","doi":"10.5114/DR.2017.66216","DOIUrl":"https://doi.org/10.5114/DR.2017.66216","url":null,"abstract":"Introduction. Skin tags are known to be associated with several systemic diseases such as diabetes mellitus, obesity, dyslipidemia and cardiovascular diseases. Only a few Indian studies have investigated patients with skin tags for underlying metabolic complications. Objective. To assess the clinico-epidemiological profile of patients with skin tags and evaluate them for underlying metabolic abnormalities. Material and methods. All the patients reporting skin tag(s) at the dermatology outpatient department from October 2013 to September 2014 were included in the study. A detailed general, cutaneous and systemic examination was carried out. The data were analyzed using the c2 test. A p-value < 0.05 was considered significant. Results. Out of 165 enrolled patients, 112 (67.88%) completed the study protocol. Females outnumbered males, the M : F ratio being 1 : 1.11. Most patients (32; 28.57%) were in the age group of 31–40 years. The majority of the patients (77; 68.75%) reported after 1 year of noticing the lesions. The most commonly affected site was the neck (99; 88.39%) followed by the axilla (53; 47.32%). Acanthosis nigricans was the most common skin disease associated with skin tags (37; 33.03%). The diagnostic criteria for metabolic syndrome were fulfilled by 47 (41.96%) patients. The majority of the patients (70; 62.5%) were either overweight or obese. Abnormal glucose tolerance and hypertension were found in 41 (36.6%) and 37 (33.03%) of the patients respectively. Above optimal LDL cholesterol was the most common lipid abnormality, detected in 64 (56.25%) of the cases. Patients with 11 or more skin tags lesions and those with involvement of the thigh, axilla or neck were more likely to have metabolic syndrome. Conclusions. Patients with skin tags should be screened for concomitant diseases such as diabetes, hypertension, dyslipidemia and cardiovascular disease. Early detection of these complications followed by appropriate lifestyle changes and/or drug therapy would be beneficial in terms of reducing the considerable morbidity and mortality. StreSzczenie Wprowadzenie. Włókniaki miękkie (nitkowate, ang. skin tags) występują u pacjentów z cukrzycą, otyłością, dyslipidemią i chorobami układu krążenia. Tylko w kilku pracach indyjskich poszukiwano współistniejących z włókniakami miękkimi chorób metabolicznych. Key WordS: skin tags, metabolic syndrome, acanthosis nigricans, insulin resistance. SłoWA KLuczoWe: włókniaki miękkie, zespół metaboliczny, rogowacenie ciemne, insulinooporność. AddreSS for correSpondence: Ankita Srivastava MD Department of Dermatology, RuhS College of Medical Sciences Jaipur, Rajasthan, India 302033 phone: 917597272523 e-mail: ankitarnt@gmail.com","PeriodicalId":20732,"journal":{"name":"Przeglad dermatologiczny","volume":"233 1","pages":"1-8"},"PeriodicalIF":0.7,"publicationDate":"2017-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/DR.2017.66216","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71072860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marek Konop, Joanna Czuwara, A. Laskowska, E. Kłodzińska, Tatsiana Damps, U. Zielenkiewicz, Iwona Baranowska, A. Misicka, L. Rudnicka
{"title":"Wpływ preparatów keratynowych na proces gojenia ran w mysim modelu rany chirurgicznej","authors":"Marek Konop, Joanna Czuwara, A. Laskowska, E. Kłodzińska, Tatsiana Damps, U. Zielenkiewicz, Iwona Baranowska, A. Misicka, L. Rudnicka","doi":"10.5114/dr.2017.67544","DOIUrl":"https://doi.org/10.5114/dr.2017.67544","url":null,"abstract":"","PeriodicalId":20732,"journal":{"name":"Przeglad dermatologiczny","volume":"104 1","pages":"234-234"},"PeriodicalIF":0.7,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71072943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"70-lecie Oddziału Morskiego Polskiego Towarzystwa Dermatologicznego Gdańsk 1946–2016","authors":"Elżbieta Grubska-Suchanek, R. Nowicki","doi":"10.5114/dr.2016.64455","DOIUrl":"https://doi.org/10.5114/dr.2016.64455","url":null,"abstract":"","PeriodicalId":20732,"journal":{"name":"Przeglad dermatologiczny","volume":"103 1","pages":"500-503"},"PeriodicalIF":0.7,"publicationDate":"2016-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/dr.2016.64455","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71072754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Atopic dermatitis is a frequent, chronic and recurrent inflammatory skin disease with complex etiology. Typical symptoms of this disease are persistent itching and dry skin. To assess the severity of the disease we use various measuring methods. Currently, over 20 different measurement scales have been developed, of which the Scoring Atopic Dermatitis Index (SCORAD) and Eczema Area and Severity Index (EASI) are best known. Other methods for measuring the severity of atopic dermatitis include: Investigators’ Global Assessment (IGA), Patient-oriented Eczema Measure (POEM), Six Area, Six Sign Atopic Dermatitis (SASSAD), Three Item Severity (TIS), Simple Scoring System (SSS), Basic Clinical Scoring System (BCSS), Patient-Oriented Scoring of Atopic Dermatitis (PO-SCORAD), Self-Administered Eczema Area and Severity Index (SA-EASI), Index for Atopic Dermatitis (W-AZS), Atopic Dermatitis Antecubital Severity (ADAS), Objective Severity Assessment of Atopic Dermatitis (OSAAD), and Visual Analogue Scale (VAS). There is no recommendation as to which scale is the most reliable in daily clinical practice. The international working group HOME (Harmonising Outcome Measures for Eczema) recommends EASI and POEM in atopic eczema trials. Metody oceny nasilenia atopowego zapalenia skóry Assessment of the severity of atopic dermatitis Agnieszka bożek, Adam reich Katedra i Klinika Dermatologii, Wenerologii i Alergologii Uniwersytetu Medycznego we Wrocławiu Przegl Dermatol 2016, 103, 479–485 DOI: 10.5114/dr.2016.63839 SłowA kluczowe: atopowe zapalenie skóry, ocena, nasilenie, skale. key wordS: atopic dermatitis, evaluation, severity, scales. AdreS do koreSpondencji: dr hab. med. Adam Reich, prof. nadzw. Katedra i Klinika Dermatologii, Wenerologii i Alergologii Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu ul. Chałubińskiego 1 50-368 Wrocław tel.: +48 71 784 22 92 faks: +48 71 327 09 99 e-mail: adam.reich@umed.wroc.pl
特应性皮炎是一种常见、慢性、反复发作的炎症性皮肤病，病因复杂。这种疾病的典型症状是皮肤持续瘙痒和干燥。为了评估疾病的严重程度，我们使用了各种测量方法。目前，已经开发了20多种不同的测量量表，其中最著名的是评分特应性皮炎指数(SCORAD)和湿疹面积和严重程度指数(EASI)。其他测量特应性皮炎严重程度的方法包括:调查人员总体评估(IGA)、患者导向湿疹量表(POEM)、六区六征特应性皮炎(SASSAD)、三项严重程度(TIS)、简单评分系统(SSS)、基本临床评分系统(BCSS)、患者导向特应性皮炎评分(PO-SCORAD)、自行给药湿疹面积及严重程度指数(SA-EASI)、特应性皮炎指数(W-AZS)、特应性皮炎前严重程度(ADAS)、特应性皮炎客观严重程度评估(OSAAD)、视觉模拟量表(VAS)。在日常临床实践中，没有推荐哪种量表是最可靠的。国际工作组HOME(协调湿疹结果测量)推荐在特应性湿疹试验中使用EASI和POEM。方法:atopowe zapalenie skóry特应性皮炎严重程度的评估Agnieszka bożek, Adam reich Katedra i Klinika Dermatologii, Wenerologii过敏症，Uniwersytetu Medycznego . Wrocławiu中华医学会皮肤病学杂志，2016,103,479-485 DOI: 10.5114/dr.2016.63839 SłowA kluczowe: atopowe zapalenie skóry, ocena, nasilenie, skale。关键词:特应性皮炎;评价;严重程度;地址:hab博士。Adam Reich，教授。中国皮肤科，中国泌尿外科，中国泌尿外科，中国泌尿系统医学。Piastów Śląskich我们Wrocławiu ul。Chałubińskiego 1 50-368 Wrocław电话:+48 71 784 22 92传真:+48 71 327 09 99电子邮件:adam.reich@umed.wroc.pl
{"title":"Assessment of the severity of atopic dermatitis","authors":"A. Bożek, A. Reich","doi":"10.5114/DR.2016.63839","DOIUrl":"https://doi.org/10.5114/DR.2016.63839","url":null,"abstract":"Atopic dermatitis is a frequent, chronic and recurrent inflammatory skin disease with complex etiology. Typical symptoms of this disease are persistent itching and dry skin. To assess the severity of the disease we use various measuring methods. Currently, over 20 different measurement scales have been developed, of which the Scoring Atopic Dermatitis Index (SCORAD) and Eczema Area and Severity Index (EASI) are best known. Other methods for measuring the severity of atopic dermatitis include: Investigators’ Global Assessment (IGA), Patient-oriented Eczema Measure (POEM), Six Area, Six Sign Atopic Dermatitis (SASSAD), Three Item Severity (TIS), Simple Scoring System (SSS), Basic Clinical Scoring System (BCSS), Patient-Oriented Scoring of Atopic Dermatitis (PO-SCORAD), Self-Administered Eczema Area and Severity Index (SA-EASI), Index for Atopic Dermatitis (W-AZS), Atopic Dermatitis Antecubital Severity (ADAS), Objective Severity Assessment of Atopic Dermatitis (OSAAD), and Visual Analogue Scale (VAS). There is no recommendation as to which scale is the most reliable in daily clinical practice. The international working group HOME (Harmonising Outcome Measures for Eczema) recommends EASI and POEM in atopic eczema trials. Metody oceny nasilenia atopowego zapalenia skóry Assessment of the severity of atopic dermatitis Agnieszka bożek, Adam reich Katedra i Klinika Dermatologii, Wenerologii i Alergologii Uniwersytetu Medycznego we Wrocławiu Przegl Dermatol 2016, 103, 479–485 DOI: 10.5114/dr.2016.63839 SłowA kluczowe: atopowe zapalenie skóry, ocena, nasilenie, skale. key wordS: atopic dermatitis, evaluation, severity, scales. AdreS do koreSpondencji: dr hab. med. Adam Reich, prof. nadzw. Katedra i Klinika Dermatologii, Wenerologii i Alergologii Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu ul. Chałubińskiego 1 50-368 Wrocław tel.: +48 71 784 22 92 faks: +48 71 327 09 99 e-mail: adam.reich@umed.wroc.pl","PeriodicalId":20732,"journal":{"name":"Przeglad dermatologiczny","volume":"61 1","pages":"479-485"},"PeriodicalIF":0.7,"publicationDate":"2016-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/DR.2016.63839","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71072673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Rosacea – new data on pathogenesis and treatment","authors":"W. Placek, H. Wolska","doi":"10.5114/DR.2016.62891","DOIUrl":"https://doi.org/10.5114/DR.2016.62891","url":null,"abstract":"","PeriodicalId":20732,"journal":{"name":"Przeglad dermatologiczny","volume":"103 1","pages":"387-399"},"PeriodicalIF":0.7,"publicationDate":"2016-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/DR.2016.62891","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71073036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction. Progressive macular hypomelanosis (PMH) is a cutaneous pigmentary disorder resulting from a deficit of melanin and manifesting with disseminated hypopigmented macules. Pityriasis alba, post-inflammatory hypopigmentation (atopic dermatitis, psoriasis), bacterial and fungal infections, neoplasms, vitiligo, piebaldism, nevus anemicus and idiopathic guttate hypomelanosis are included in the differential diagnosis. No commonly accepted therapeutic recommendations have been published so far; topical antibiotics, phototherapy and oral isotretinoin have been described in the literature. Objective. To present our own cases of PMH – a dermatosis which is somewhat common in the general population but is still diagnosed infrequently in clinical practice. Progressive macular hypomelanosis: częste schorzenie rzadko rozpoznawane w praktyce klinicznej Progressive macular hypomelanosis: a common disorder rarely diagnosed in clinical practice Marta Pelc, radomir reszke, Jacek Szepietowski Katedra i Klinika Dermatologii, Wenerologii i Alergologii Uniwersytetu Medycznego we Wrocławiu Przegl Dermatol 2016, 103, 362–366 DOI: 10.5114/dr.2016.62886 SłowA kluczowe: dyschromia, progressive macular hypomelanosis, Propionibacterium acnes. key wordS: dyschromia, progressive macular hypomelanosis, Propionibacterium acnes. AdreS do koreSPondencJi: prof. dr hab. n. med. Jacek Szepietowski Katedra i Klinika Dermatologii, Wenerologii i Alergologii Uniwersytet Medyczny ul. Chalubinskiego 1 50-368 Wrocław tel.: +48 601 534 853 e-mail: jacek.szepietowski@ umed.wroc.pl
介绍。进行性黄斑低黑症(PMH)是一种由黑色素缺乏引起的皮肤色素紊乱，表现为弥散性低色素斑。白斑糠疹、炎症后色素减退(特应性皮炎、银屑病)、细菌和真菌感染、肿瘤、白癜风、斑疹病、痣贫血和特发性点滴性低黑素症都包括在鉴别诊断中。到目前为止，还没有发表普遍接受的治疗建议;局部抗生素，光疗和口服异维甲酸已在文献中描述。目标。介绍我们自己的病例PMH -这是一种皮肤病，在一般人群中有些常见，但在临床实践中仍然很少诊断。Marta Pelc, radomir reszke, Jacek Szepietowski Katedra i Klinika Dermatologii, Wenerologii i过敏症，universystemtu Medycznego . Wrocławiu przegegl dermatology, 2016.62886 SłowA kluczowe:色素障碍，进行性黄斑性低黑症，痤疮丙酸杆菌。关键词:色素沉着，进行性黄斑低黑症，痤疮丙酸杆菌。地址:李洪志教授。医学博士，Jacek Szepietowski Katedra i Klinika皮肤病学，神经过敏学，大学系统医学。Chalubinskiego 1 50-368 Wrocław电话:+48 601 534 853电子邮件:jacek。szepietowski@ umed.wroc.pl
{"title":"Progressive macular hypomelanosis: a common disorder rarely diagnosed in clinical practice","authors":"M. Pelc, Radomir Reszke, J. Szepietowski","doi":"10.5114/DR.2016.62886","DOIUrl":"https://doi.org/10.5114/DR.2016.62886","url":null,"abstract":"Introduction. Progressive macular hypomelanosis (PMH) is a cutaneous pigmentary disorder resulting from a deficit of melanin and manifesting with disseminated hypopigmented macules. Pityriasis alba, post-inflammatory hypopigmentation (atopic dermatitis, psoriasis), bacterial and fungal infections, neoplasms, vitiligo, piebaldism, nevus anemicus and idiopathic guttate hypomelanosis are included in the differential diagnosis. No commonly accepted therapeutic recommendations have been published so far; topical antibiotics, phototherapy and oral isotretinoin have been described in the literature. Objective. To present our own cases of PMH – a dermatosis which is somewhat common in the general population but is still diagnosed infrequently in clinical practice. Progressive macular hypomelanosis: częste schorzenie rzadko rozpoznawane w praktyce klinicznej Progressive macular hypomelanosis: a common disorder rarely diagnosed in clinical practice Marta Pelc, radomir reszke, Jacek Szepietowski Katedra i Klinika Dermatologii, Wenerologii i Alergologii Uniwersytetu Medycznego we Wrocławiu Przegl Dermatol 2016, 103, 362–366 DOI: 10.5114/dr.2016.62886 SłowA kluczowe: dyschromia, progressive macular hypomelanosis, Propionibacterium acnes. key wordS: dyschromia, progressive macular hypomelanosis, Propionibacterium acnes. AdreS do koreSPondencJi: prof. dr hab. n. med. Jacek Szepietowski Katedra i Klinika Dermatologii, Wenerologii i Alergologii Uniwersytet Medyczny ul. Chalubinskiego 1 50-368 Wrocław tel.: +48 601 534 853 e-mail: jacek.szepietowski@ umed.wroc.pl","PeriodicalId":20732,"journal":{"name":"Przeglad dermatologiczny","volume":"119 1","pages":"362-366"},"PeriodicalIF":0.7,"publicationDate":"2016-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/DR.2016.62886","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71073017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D. Mehrholz, P. Domagala, E. Zielińska, W. Barańska-Rybak
{"title":"Innovative methods of biofilm treatment in chronic wounds","authors":"D. Mehrholz, P. Domagala, E. Zielińska, W. Barańska-Rybak","doi":"10.5114/DR.2016.61779","DOIUrl":"https://doi.org/10.5114/DR.2016.61779","url":null,"abstract":"","PeriodicalId":20732,"journal":{"name":"Przeglad dermatologiczny","volume":"103 1","pages":"295-302"},"PeriodicalIF":0.7,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/DR.2016.61779","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71072608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Krajewska, H. Bartosik, W. Krajewski, A. Hałoń, M. Klinger
{"title":"Dermatomyositis as a paraneoplastic syndrome of malignant melanoma or incidental coexistence","authors":"M. Krajewska, H. Bartosik, W. Krajewski, A. Hałoń, M. Klinger","doi":"10.5114/DR.2016.61776","DOIUrl":"https://doi.org/10.5114/DR.2016.61776","url":null,"abstract":"","PeriodicalId":20732,"journal":{"name":"Przeglad dermatologiczny","volume":"103 1","pages":"285-288"},"PeriodicalIF":0.7,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/DR.2016.61776","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71072251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Wieczorek, J. Szepietowski, Katarzyna Łoza, A. Bizoń, Julia Lanckorońska, K. Rutkowska, Katarzyna Głogowska
Introduction. Bed bugs belong to the family Cimicidae, which includes two cosmopolitan species: Cimex lectularius and Cimex hemipterus. Bed bugs feed on the blood of humans and animals. As a result of bites, skin changes can manifest as itchy spots, erythematous-edematous lesions, hives and bullae. Aim. To describe two cases: a father and daughter living in the same household, both having skin lesions after bed bug bites that could imitate autoimmune bullous diseases. Case reports. The first case concerns a 57-year-old man on whose trunk and extremities were erythematous-edematous lesions and bullae. The second case concerns the 34-year-old daughter of the first patient, on whose trunk and extremities were linear erythematous-edematous lesions. Both in the first and second case direct and indirect immunofluorescence was negative. Conclusions. Bed bug bites can mimic other skin diseases, including autoimmune bullous diseases.
{"title":"Bed bug bites mimicking bullous pemphigoid: a report of two cases","authors":"A. Wieczorek, J. Szepietowski, Katarzyna Łoza, A. Bizoń, Julia Lanckorońska, K. Rutkowska, Katarzyna Głogowska","doi":"10.5114/DR.2016.61775","DOIUrl":"https://doi.org/10.5114/DR.2016.61775","url":null,"abstract":"Introduction. Bed bugs belong to the family Cimicidae, which includes two cosmopolitan species: Cimex lectularius and Cimex hemipterus. Bed bugs feed on the blood of humans and animals. As a result of bites, skin changes can manifest as itchy spots, erythematous-edematous lesions, hives and bullae. Aim. To describe two cases: a father and daughter living in the same household, both having skin lesions after bed bug bites that could imitate autoimmune bullous diseases. Case reports. The first case concerns a 57-year-old man on whose trunk and extremities were erythematous-edematous lesions and bullae. The second case concerns the 34-year-old daughter of the first patient, on whose trunk and extremities were linear erythematous-edematous lesions. Both in the first and second case direct and indirect immunofluorescence was negative. Conclusions. Bed bug bites can mimic other skin diseases, including autoimmune bullous diseases.","PeriodicalId":20732,"journal":{"name":"Przeglad dermatologiczny","volume":"103 1","pages":"281-284"},"PeriodicalIF":0.7,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/DR.2016.61775","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71072193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：